Commissioning and clinical implementation of the first commercial independent Monte Carlo 3D dose calculation to replace CyberKnife M6™ patient‐specific QA measurements

PURPOSE: To report on the commissioning and clinical validation of the first commercially available independent Monte Carlo (MC) three‐dimensional (3D) dose calculation for CyberKnife robotic radiosurgery system® (Accuray, Sunnyvale, CA). METHODS: The independent dose calculation (IDC) by SciMoCa® (...

Descripción completa

Detalles Bibliográficos
Autores principales: Milder, Maaike T. W., Alber, Markus, Söhn, Matthias, Hoogeman, Mischa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Technical Notes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700940/
https://www.ncbi.nlm.nih.gov/pubmed/33103343
http://dx.doi.org/10.1002/acm2.13046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700940/
https://www.ncbi.nlm.nih.gov/pubmed/33103343
http://dx.doi.org/10.1002/acm2.13046

Ejemplares similares